Skip to main content

Table 2 pCR and response rates in tissue or only lymph nodes in “control” and “intervention” groups

From: Addition of carboplatin-gemcitabine as second-line neoadjuvant chemotherapy in non-responsive locally advanced breast cancer patients to standard neoadjuvant chemotherapy and evaluation of factors affecting response: a randomized controlled trial

Response

group

P value

control n = 27

n (%)

intervention n = 25

n (%)

pCR

8 (29.6%)

8 (32%)

0.853

Breast tissue

14 (51.9%)

12 (48%)

0.781

Lymph nodes

11 (40.7%)

11 (44%)

0.812

  1. pCR pathologic complete response